|Year : 2019 | Volume
| Issue : 3 | Page : 193-198
Unmet need of antenatal screening for asymptomatic bacteriuria: A risk factor for adverse outcomes of pregnancy
Manish Gehani1, Suman Kapur1, Pankaj Bhardwaj2, Vijayalakshmi Nag3, Sudharsanam Manni Balasubramaniam4, Nagamani Kammili5, Sudha D Madhuri5
1 Department of Biological Sciences, Birla Institute of Technology and Science, Jodhpur, Rajasthan, India
2 Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
3 Department of Microbiology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
4 Department of Evidence Measurement and Evaluation, Children's Investment Fund Foundation, Delhi, India
5 Department of Microbiology, Gandhi Medical College, Hyderabad, Telangana, India
|Date of Submission||20-Nov-2018|
|Date of Acceptance||31-Jul-2019|
|Date of Web Publication||20-Sep-2019|
Dr. Manish Gehani
Department of Biological Sciences, Birla Institute of Technology and Science, Pilani, Hyderabad Campus, Hyderabad - 500 078, Telangana
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Recommended urine culture is unsuitable for screening pregnant women for asymptomatic bacteriuria due to long turn-around time, unaffordability, and user-unfriendliness. The objective of this review was to evaluate the suitability of various tests for this purpose. A PubMed-based systematic review of published articles irrespective of year and language was done. Search terms included asymptomatic bacteriuria, screening test, urinary tract infection, and diagnostic test. Diagnostic accuracy studies conducted on human populations comparing tests with urine culture were included. One author extracted predefined data fields, including quality indicators, another validated it. Of 78 records, 25 studies describing 15 tests were included. All tests were rapid, seven were valid and two of them were affordable and easy-to-use. No test provided comprehensive identification with antibiotic susceptibility. Despite publication bias, no test was found suitable for screening asymptomatic bacteriuria antenatally and providing evidence-based prescription. Further research is needed to develop tests which suit this purpose.
Keywords: Antenatal screening, asymptomatic bacteriuria, diagnostic accuracy
|How to cite this article:|
Gehani M, Kapur S, Bhardwaj P, Nag V, Balasubramaniam SM, Kammili N, Madhuri SD. Unmet need of antenatal screening for asymptomatic bacteriuria: A risk factor for adverse outcomes of pregnancy. Indian J Community Med 2019;44:193-8
|How to cite this URL:|
Gehani M, Kapur S, Bhardwaj P, Nag V, Balasubramaniam SM, Kammili N, Madhuri SD. Unmet need of antenatal screening for asymptomatic bacteriuria: A risk factor for adverse outcomes of pregnancy. Indian J Community Med [serial online] 2019 [cited 2019 Dec 7];44:193-8. Available from: http://www.ijcm.org.in/text.asp?2019/44/3/193/267353
| Introduction|| |
During pregnancy, a woman is predisposed to asymptomatic bacteriuria, as a result of anatomical and functional changes in the urinary tract and reduction in immunity., Additional risk is posed, especially to pregnant women in low-income countries due to low socioeconomic status, advanced maternal age, multiparity, increasing period of gestation, poor sanitation, lack of general hygiene, early marriage, first pregnancy at a younger age, lack of adequate treatment, and failure to attend antenatal clinic., Nearly, 1.9%–9.5% pregnancies are affected by asymptomatic bacteriuria worldwide, more commonly due to Gram-negative bacteria like Escherichia More Details coli, Klebsiella, Proteus, and Pseudomonas, than Gram-positive bacteria like Streptococcus, Staphylococcus, and Enterococcus.
Asymptomatic bacteriuria in pregnancy, if undetected and untreated, can lead to various adverse outcomes, either insidiously or by progressing to symptomatic urinary tract infections (UTIs). In mother, it causes preterm labor, hypertensive disorders of pregnancy, preterm premature rupture of membranes, anemia, postpartum endometritis, and acute pyelonephritis, while in the baby, it leads to intrauterine growth retardation, prematurity, low birth weight, and perinatal mortality. Prematurity affects 15 million babies every year globally and is further responsible for at least 50% of all the neonatal deaths worldwide. Even if the children survive it, they may suffer lifelong physical, neurodevelopmental, behavioral, or learning disability. The cost of long care burdens the families economically, emotionally, and psychosocially.
Screening for asymptomatic bacteriuria and its subsequent treatment has shown reduction in its adverse outcomes, especially in the risk of pyelonephritis,, preterm delivery, and low birth weight babies., Based on the current evidence and expert opinions, Infectious Diseases Society of America  and US Preventive Service Task Force Recommendation  recommend urine culture for screening every pregnant woman for asymptomatic bacteriuria at least once between 12 and 16 weeks' gestation or during the first prenatal visit. If the test results come positive, the woman should be treated with antimicrobials.
An estimated 213 million pregnancies occur in a year worldwide  and 60% of these attend antenatal checkups. The recommended test for screening this large population for asymptomatic bacteriuria, urine culture, is hardly suitable for this task. It is resource intensive, unaffordable, and not available  in low-resource settings where the majority of pregnant women come for antenatal checkups. It needs a laboratory setup  with incubator, autoclave, laminar airflow and dedicated air-conditioned space, resources for streaking, performing reactions for identification, and conducting disk-diffusion for antibiotic susceptibility. It is not user-friendly and needs trained personnel to execute the test, making it even more difficult for grass-root staff to provide this test. Further, it takes 48–72 h to give results when done manually and 24 h when expensive automated systems are used. It is difficult for a woman to come back to the hospital on the 2nd or 3rd day, when the culture and sensitivity reports come. For these reasons, screening each pregnant woman for asymptomatic bacteriuria requires a test which is rapid, valid, inexpensive, user-friendly, and which provides antibiotic susceptibility so as to facilitate evidence-based prescription for positive cases without needing a repeat visit.
The rationale of this mini-review was that it was needed to know whether we have a suitable test for screening asymptomatic bacteriuria in large population with potential for providing evidence-based prescription quickly or there is a gap in research, so as to suggest a basis for further research.
The objectives of the review were to find out:
- What are the tests researched for screening asymptomatic bacteriuria or diagnosing UTI in published literature?
- Are they rapid, valid, affordable, and user-friendly for use in large population?
- Do they screen or diagnose multiple bacteria and provide antibiotic susceptibility?
| Methods|| |
This review is designed as a narrative review. Methods of conducting the review and eligibility criteria were documented in advance. Diagnostic accuracy studies researching diagnostic tests for UTI or screening tests for asymptomatic bacteriuria in humans as compared to urine culture were included. All types of published articles were considered irrespective of year or language of publication. Participants of any age group screened for asymptomatic bacteriuria or diagnosed with UTI in any level of care hospital were considered. The primary outcome measure was cases of UTI or asymptomatic bacteriuria correctly diagnosed by the tests.
Studies were identified by searching electronic database of Medline. Two searches were conducted on PubMed using the following search terms:
- “Urinary tract infection” and “diagnostic test”
- “Asymptomatic bacteriuria” and “screening test.”
No filters were applied. Eligibility assessment was done by two reviewers independently in an unblinded standardized manner by screening the titles and abstracts. Full-text publications were reviewed for selected papers. Disagreement between reviewers was resolved by consultation with other coauthors. Two studies required arbitration about selection, the remaining were agreed independently by the reviewers. The last search was run on June 19, 2019. An Excel-based data extraction sheet was developed and piloted on five randomly selected studies. One reviewer extracted data from included studies and the second author validated the extracted data. No disagreement was encountered in data extraction. Information was extracted from each included study on-
- Characteristics of participants – age, presence of symptoms, cohorts
- Details of intervention, name, automated or manual, intended use, comparator
- Outcomes and results of tests conducted; cutoff points used
- Study design, sample size, prospective nature.
The risk of bias in individual studies was assessed by looking at their sample size and prospective nature.
Sensitivity, specificity, likelihood ratios, or receiver operating characteristic were considered the principal summary measures. Sensitivity and specificity above 80% were considered as valid. Likelihood ratios were converted to sensitivity and specificity. Among the studies describing the similar intervention, the highest diagnostic accuracy was considered. Studies were reviewed for explicit mention of terms rapid, cost-effective/affordable, or user-friendly, and the description of index test was reviewed for determining these criteria.
Screening only one database and only published articles introduced publication bias. No additional analyses were performed.
| Results|| |
Seventy-eight records were retrieved from the electronic database, while 25 studies ,,,,,,,,,,,,,,,,,,,,,,,, were retained for qualitative synthesis [Figure 1]. The researchers had studied 11 individual tests and 7 combinations of various tests [Figure 1]. The report characteristics and study characteristics are described in [Table 1].
|Figure 1: Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram|
Click here to view
In one study, diagnostic accuracy was separately described for males and females, while in two of the studies, separate cohorts of asymptomatic and symptomatic patients were evaluated. Since the review is concerned with asymptomatic women, the diagnostic accuracy in asymptomatic patients and female patients were considered. Out of 15 tests studied in 25 papers [Table 2], all were rapid in nature, but only seven were valid, namely, genetic signature identification CAPTURE assay, microfluidics-based direct single-cell imaging test, biosensor assay and phenotypic antimicrobial susceptibility test, chromogenic Limulus amoebocyte lysate assay, Gram staining, urine particle analyser UF-1000i, and flow cytometry-based leukocyte count (UF 100). Out of these tests, review of required infrastructure as described in the papers revealed that Gram staining and chromogenic Limulus amoebocyte lysate assay were cost-effective for use in large population. While the study on chromogenic Limulus amoebocyte lysate assay explicitly mentioned that it was user-friendly, the procedure to conduct Gram stain was deemed to be user-friendly by the authors.
None of the 15 tests was equipped to provide both identification of common uropathogens as well as susceptibility to various antibiotics for evidence-based prescription at the time of the first contact itself. Biosensor assay identified Enterobacteriaceae but gave susceptibility to only ciprofloxacin. CAPTURE assay identified common uropathogens but did not provide antibiotic susceptibility. Microfluidics-based test identified only E. coli and provided susceptibility to only ciprofloxacin. Gram staining could differentiate Gram-positive bacteria from Gram-negative bacteria. While the rest of the 11 tests were used in the role of triage tests for initial diagnosis of UTI to reduce the burden of performing urine culture on every sample.
No combination of tests proved to be valid unequivocally. Nitrite and leukocyte esterase together showed validity in two studies but failed to show validity in five studies.
| Discussion|| |
Many hospitals in low-resource settings, lack the resources to screen every pregnant woman using the urine culture, and sensitivity test. As a result, they either do not screen them at all or screen them with tests having low diagnostic accuracy.
In our review of the literature, none of the alternative tests tried in the past had all the characteristics of a suitable test for screening asymptomatic bacteriuria, namely, rapid, valid, user-friendly, affordable, and providing identification and antibiotic sensitivity. Most of the tests just provided an initial triage of UTI so as to reduce the need of running urine culture for every sample. A positive woman on screening had to still undergo urine culture and wait for 2 days for initiation of appropriate antibiotic therapy, which in reality never happens. The women fail to come back to the hospital on the 2nd or 3rd day, when the culture and sensitivity reports come, due to many factors like lack of conveyance, cost of transportation, lack of compliance, and discomfort of repeated visits. Hence, they fail to avail adequate treatment with desirable and effective antimicrobials.
This reveals a state of affairs where 40% women  do not turn up for antenatal checkups, among the rest, majority do not get an early diagnosis and initiation of appropriate antibiotics. This leaves an unmet need in adequately screening the pregnant women during early pregnancy for asymptomatic bacteriuria, contributing to adverse outcomes of pregnancy.
Similarly, in cases of symptomatic pregnant women, treating physicians are unable to timely find out the causative organism and susceptibility. They are forced to mostly rely on their clinical judgment and prescribe wide-spectrum antibiotics empirically. Nonevidence-based irrational and unnecessary drug prescription of antibiotics has raised the rate of development of antimicrobial resistance for several commonly used broad-spectrum antibiotics.
Despite the limitations like not being an extensive search in various databases and unpublished articles, the review provided an insight into why pregnant women are not being screened routinely and how it is contributing to a rise in cases of prematurity.
According to United States Preventive Services Task Force (USPTF), it is urgently needed to develop a test, which can screen for asymptomatic bacteriuria and is less labor-intensive at a lower cost too. The authors also conclude that for making this testing possible in all health-care settings, further research is needed to provide an affordable, easy, rapid, and valid test for identification of bacteria and antibiotic sensitivity. Failing to do so will leave asymptomatic bacteriuria undiagnosed and will cause adverse outcomes of pregnancy.
Support provided by BITS Pilani, Hyderabad Campus, India, and editorial help by Dr. Shashwat Sharad, CPDR, USA, is gratefully acknowledged.
Financial support and sponsorship
This study was funded by GYTI-SRISTI grant of Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology (DBT), Government of India.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Delzell JE Jr., Lefevre ML. Urinary tract infections during pregnancy. Am Fam Physician 2000;61:713-21.
Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM, et al.
Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005;40:643-54.
Gupta S, Kapur S, Padmavathi D. Comparative prevalence of antimicrobial resistance in community-acquired urinary tract infection cases from representative states of Northern and Southern India. J Clin Diagn Res 2014;8:DC09-12.
Jain V, Das V, Agarwal A, Pandey A. Asymptomatic bacteriuria and obstetric outcome following treatment in early versus late pregnancy in North Indian women. Indian J Med Res 2013;137:753-8.
] [Full text]
Howson CP, Kinney MV, McDougall L, Lawn JE; Born Too Soon Preterm Birth Action Group. Born too soon: Preterm birth matters. Reprod Health 2013;10 Suppl 1:S1.
Smaill FM, Vazquez JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 2015;8:CD000490.
Romero R, Oyarzun E, Mazor M, Sirtori M, Hobbins JC, Bracken M, et al.
Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet Gynecol 1989;73:576-82.
U.S. Preventive Services Task Force. Screening for asymptomatic bacteriuria in adults: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 2008;149:43-7.
Sedgh G, Singh S, Hussain R. Intended and unintended pregnancies worldwide in 2012 and recent trends. Stud Fam Plann 2014;45:301-14.
World Health Organization. World Health Statistics 2018: Monitoring Health for the SDGs, Sustainable Development Goals. Geneva: World Health Organization; 2018. p. 86.
Lumbiganon P, Laopaiboon M, Thinkhamrop J. Screening and treating asymptomatic bacteriuria in pregnancy. Curr Opin Obstet Gynecol 2010;22:95-9.
Ajayi AB, Nwabuisi C, Aboyeji PO, Fowotade A, Fakeye OO. Reliability of urine multistix and gram stain in the detection of asymptomatic bacteriuria in pregnancy. West Afr J Med 2010;29:339-43.
Yodoshi T, Matsushima M, Taniguchi T, Kinjo S. Utility of point-of-care gram stain by physicians for urinary tract infection in children ≤36 months. Medicine (Baltimore) 2019;98:e15101.
O'Keefe LC, Koelle P, McGee Z, Dewberry LS, Wright C, Stallings JE, et al.
Innovations in worksite diagnosis of urinary tract infections and the occupational health nurse. Workplace Health Saf 2019;67:268-74.
Etminan-Bakhsh M, Tadi S, Darabi R. Asymptomatic bacteriuria in pregnant women attending Boo-Ali hospital Tehran Iran: Urine analysis vs. urine culture. Electron Physician 2017;9:5760-3.
Baltekin Ö, Boucharin A, Tano E, Andersson DI, Elf J. Antibiotic susceptibility testing in less than 30 min using direct single-cell imaging. Proc Natl Acad Sci U S A 2017;114:9170-5.
Duong HP, Wissing KM, Tram N, Mascart G, Lepage P, Ismaili K, et al.
Accuracy of automated flow cytometry-based leukocyte counts to rule out urinary tract infection in febrile children: A prospective cross-sectional study. J Clin Microbiol 2016;54:2975-81.
Moshaver B, de Boer F, van Egmond-Kreileman H, Kramer E, Stegeman C, Groeneveld P, et al.
Fast and accurate prediction of positive and negative urine cultures by flow cytometry. BMC Infect Dis 2016;16:211.
Cariou G, El Basri A, Cohen J, Cortesse A. Can the urine dipstick be used in the diagnosis of urinary bacterial colonizations in a preoperative urological assessment? Prog Urol 2016;26:276-80.
Altobelli E, Mohan R, Mach KE, Sin ML, Anikst V, Buscarini M, et al.
Integrated biosensor assay for rapid uropathogen identification and phenotypic antimicrobial susceptibility testing. Eur Urol Focus 2017;3:293-9.
Dai Q, Jiang Y, Shi H, Zhou W, Zhou S, Yang H, et al.
Evaluation of the automated urine particle analyzer UF-1000i screening for urinary tract infection in nonpregnant women. Clin Lab 2014;60:275-80.
Kutlay S, Kutlay B, Karaahmetoglu O, Ak C, Erkaya S. Prevalence, detection and treatment of asymptomatic bacteriuria in a Turkish obstetric population. J Reprod Med 2003;48:627-30.
Waisman Y, Zerem E, Amir L, Mimouni M. The validity of the uriscreen test for early detection of urinary tract infection in children. Pediatrics 1999;104:e41.
Lachs MS, Nachamkin I, Edelstein PH, Goldman J, Feinstein AR, Schwartz JS, et al.
Spectrum bias in the evaluation of diagnostic tests: Lessons from the rapid dipstick test for urinary tract infection. Ann Intern Med 1992;117:135-40.
Aigere EO, Okusanya BO, Eigbefoh JO, Okome GB. Enhanced urinalysis in the detection of asymptomatic bacteriuria in pregnancy. Nig Q J Hosp Med 2013;23:105-9.
Thakre SS, Dhakne SS, Thakre SB, Thakre AD, Ughade SM, Kale P, et al.
Can the griess nitrite test and a urinary pus cell count of ≥5 cells per micro litre of urine in pregnant women be used for the screening or the early detection of urinary tract infections in rural India? J Clin Diagn Res 2012;6:1518-22.
Ullah A, Barman A, Ahmed I, Salam A. Asymptomatic bacteriuria in pregnant mothers: A valid and cost-effective screening test in Bangladesh. J Obstet Gynaecol 2012;32:37-41.
Kovavisarach E, Vichaipruck M, Kanjanahareutai S. Reagent strip testing for antenatal screening and first meaningful of asymptomatic bacteriuria in pregnant women. J Med Assoc Thai 2008;91:1786-90.
Teppa RJ, Roberts JM. The uriscreen test to detect significant asymptomatic bacteriuria during pregnancy. J Soc Gynecol Investig 2005;12:50-3.
Greeff A, Jeffery B, Pattinson RC. Uricult trio as a screening test for bacteriuria in pregnancy. S Afr Med J 2002;92:306-9.
McNair RD, MacDonald SR, Dooley SL, Peterson LR. Evaluation of the centrifuged and gram-stained smear, urinalysis, and reagent strip testing to detect asymptomatic bacteriuria in obstetric patients. Am J Obstet Gynecol 2000;182:1076-9.
Chongsomchai C, Piansriwatchara E, Lumbiganon P, Pianthaweechai K. Screening for asymptomatic bacteriuria in pregnant women: Urinalysis versus urine culture. J Med Assoc Thai 1999;82:369-73.
Mathews JE, George S, Mathews P, Mathai E, Brahmadathan KN, Seshadri L, et al.
The griess test: An inexpensive screening test for asymptomatic bacteriuria in pregnancy. Aust N
Z J Obstet Gynaecol 1998;38:407-10.
Ouslander JG, Schapira M, Fingold S, Schnelle J. Accuracy of rapid urine screening tests among incontinent nursing home residents with asymptomatic bacteriuria. J Am Geriatr Soc 1995;43:772-5.
Robertson AW, Duff P. The nitrite and leukocyte esterase tests for the evaluation of asymptomatic bacteriuria in obstetric patients. Obstet Gynecol 1988;71:878-81.
Nachum R, Arce JJ, Berzofsky RN. Gram-negative bacteriuria of pregnancy: Rapid detection by a chromogenic Limulus
amoebocyte lysate assay. Obstet Gynecol 1986;68:215-9.
Mathai E, Thomas RJ, Chandy S, Mathai M, Bergstrom S. Antimicrobials for the treatment of urinary tract infection in pregnancy: Practices in Southern India. Pharmacoepidemiol Drug Saf 2004;13:645-52.
[Table 1], [Table 2]